Chinese bribery investigation accuses GlaxoSmithLine of being ringleader
Four GSK executives are detained as police investigate bribery scandal
Chinese police accused GlaxoSmithKline of being the “ringleader” in a massive bribery scandal on Monday, involving as many as 700 middlemen and ¥3 billion (£320m) in bribes over the last six years.
Four GSK executives have been detained amid claims that they bribed Chinese officials, doctors and hospitals to boost sales illegally and raise prices of medicines. Police said GSK employees received bribes “of a sexual nature” as well as cash bribes from middlemen travel companies.
“We found that bribery is a core part of the activities of the company,” said Gao Feng, head of the economic crime investigation division of China’s Ministry of Public Security. “To boost their prices and sales, the company performed illegal actions.”
The detainees are Chinese nationals employed by GSK in China as head of compliance, vice-president in charge of operations, commercial development manager and human resources director, Mr Gao said.
He added that the British head of Glaxo’s business in China, Mark Reilly, had left the country on 27 June, after the inquiry was announced. “You better ask him yourself why he has left China,” Mr Gao said. “We did not take any measures to stop his departure.”
It is understood that Mr Reilly returned to the UK for a planned business meeting, but is now staying in the UK to work with Glaxo’s China leadership team from afar, as well as with management in the UK.
Mr Gao added that investigators had not “received any information from the UK headquarters” and “we are wondering why”.
Glaxo responded that it was “deeply concerned and disappointed by the serious allegations”. A spokesman added: “Such behaviour would be a clear breach of GSK’s systems, governance procedures, values and standards. GSK has zero tolerance for any behaviour of this nature. GSK shares the desire of the Chinese authorities to root out corruption. We will co-operate fully with the Chinese authorities in the investigation of these new allegations.
“We are reviewing all third-party agency relationships. We have put an immediate stop on the use of travel agencies that have been identified so far in this investigation, and we are conducting a thorough review of all historic transactions related to travel agency use. GSK fully respects the laws and regulations in China and expects all staff to abide by them.”
Last week the company said it had investigated bribery allegations and found no evidence of wrongdoing.
Mr Gao said: “Just like criminal organisations always have a ringleader, in this criminal scheme GSK is the ringleader. GSK is the main party responsible. It is like a criminal organisation, there is always a boss. In this game, GSK is the godfather.
He said there were “some clues” of similar activities by other foreign pharmaceutical companies, “but we haven’t ascertained whether these were illegal”.
Bitter pill: how the case developed
28 June: Police in Changsha say GSK executives are being investigated for alleged “economic crimes”.
4 July: China’s drug price body, the National Development and Reform Commission, launches inquiry into medicines costs, examining dozens of drugmakers including Glaxo.
7 July: The Wall Street Journal reports that a whistleblower notified GSK’s board of allegations that its China sales staff bribed doctors to prescribe Botox over the past year. GSK says it investigated and found no evidence of bribery or corruption.
11 July: China’s Public Security Bureau accuses GSK of bribing doctors, hospitals and officials to prescribe their drugs, and says GSK executives admitted using bribes.
13 July: GSK halts tests of an experimental multiple sclerosis medicine on human volunteers after fraud claims in a scientific paper led it to fire Jingwu Zhang, head of its neuro-immunology centre in Shanghai.
15 July: Police in China release more details on the bribery allegations and say four GSK executives had been detained.
Missing Malaysia Airlines Flight MH370: Wreckage could be found within a week as search reaches 'very critical juncture', says minister
The man they forgot to lock up: Mike Anderson was sentenced to 13 years in jail, but the police never came
Unbeliebable: The White House offers 'no comment' to anti-Justin Bieber petition
Loch Ness Monster found on Apple Maps?
South Korea ferry disaster: Families watch as remains of Sewol victims returned to shore
The food poverty scandal that shames Britain: Nearly 1m people rely on handouts to eat – and benefit reforms may be to blame
Scottish independence: It is the English who should be on their knees, begging the Scots to vote ‘No’
'Sinful': Video of British Muslims dancing to Pharrell Williams's hit Happy comes under attack
An open letter to Nigel Farage: you may smile, but I am not seduced
Nigel Farage: I’m taking on the status quo, and the Establishment’s fighting back
Abdullah Deghayes: My son was the martyr of a just cause, says father of British teenager killed in Syria conflict
- 1 Easter egg hunt horror as mother finds dead body under deck of house
- 2 A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
- 3 Unbeliebable: The White House offers 'no comment' to anti-Justin Bieber petition
- 4 Loch Ness Monster found on Apple Maps?
- 5 Criminals ‘using unmanned drones and infrared cameras to find illegal cannabis farms’ – and then steal from the growers
iJobs Money & Business
Negotiable: Harrington Starr: Database Team Lead ( Leadership, Sybase, Compute...
£40000 - £50000 per annum + Bonus+Benefits+Package: Harrington Starr: C#.NET D...
£25000 - £35000 per annum + Bonus+Benefits+Package: Harrington Starr: VB.NET S...
£45000 - £55000 per annum + Bonus and Benefits: Harrington Starr: Trade Suppor...